VEXAS Syndrome
Symptoms, Doctors, Treatments, Advances & More

VEXAS Syndrome Overview

Save information for later
Sign Up

Learn About VEXAS Syndrome

What is the definition of VEXAS Syndrome?
VEXAS syndrome is a severe inflammatory syndrome caused by a genetic mutation in bone marrow.
What are the symptoms of VEXAS Syndrome?
Symptoms of VEXAS syndrome usually occur between 45 and 80 years of age and may include recurrent fevers, inflammation of the blood vessels, fluid and infections in the lungs, skin and eye inflammation, deep vein clots, joint pain, infections of the cartilage of the ear and nose, anemia, and sensorineural hearing loss.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for VEXAS Syndrome?
There is currently no standard treatment for VEXAS syndrome. However, glucocorticoids have provided some symptom relief. Researchers are currently investigating bone marrow transplants and gene editing as possible treatments for VEXAS syndrome.
Who are the top VEXAS Syndrome Local Doctors?
Elite in VEXAS Syndrome
Mael Heiblig
Elite in VEXAS Syndrome
Mael Heiblig
Referral may be required
Pierre-la-treiche, FR 

Mael Heiblig practices practicing medicine in Pierre-la-treiche, France. Mr. Heiblig is rated as an Elite expert by MediFind in the treatment of VEXAS Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses VEXAS Syndrome, Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

Elite in VEXAS Syndrome
Arsene M. Mekinian
Elite in VEXAS Syndrome
Arsene M. Mekinian
Referral may be required
Paris, FR 

Arsene Mekinian practices practicing medicine in Paris, France. Mr. Mekinian is rated as an Elite expert by MediFind in the treatment of VEXAS Syndrome. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses VEXAS Syndrome, Takayasu Arteritis, Vasculitis, Bone Marrow Transplant, and Intrauterine Device Insertion.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in VEXAS Syndrome
Dr. David B. Beck
Medical Genetics | Rheumatology
Elite in VEXAS Syndrome
Dr. David B. Beck
Medical Genetics | Rheumatology
Referral may be required

New York University

333 E 38th St, 
New York, NY 
646-356-9400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Beck is a Medical Genetics specialist and a Rheumatologist practicing medicine in New York, New York. Dr. Beck is rated as an Elite provider by MediFind in the treatment of VEXAS Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses VEXAS Syndrome, Relapsing Polychondritis, Hypotonia, and Polyarteritis Nodosa.

View All Doctors
What are the latest VEXAS Syndrome Clinical Trials?
Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
Enrollment Status: Recruiting
Publish Date: May 15, 2026

Summary: The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Who is this study for: Patients with VEXAS syndrome
Enrollment Status: Recruiting
Publish Date: May 08, 2026
Intervention Type: Procedure, Drug, Radiation
Study Drugs: Post-Transplant Cyclophosphamide, Cyclophosphamide, Fludarabine, Busulfan, Sirolimus, Mycophenolate mofetil, Busulfan
Study Phase: Phase 2

Background: Allogeneic hematopoietic stem cell transplant involves taking blood stem cells from a donor and giving them to a recipient. The transplants are used to treat certain diseases and cancers. Researchers want to see if the transplant can treat VEXAS Syndrome.

View All Clinical Trials